Breast lymphedema following breast-conserving treatment for breast cancer: current status and future directions Cheryl L. BrunelleJohn BoyagesAlphonse G. Taghian Review 15 December 2023 Pages: 193 - 222
Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study Miaomiao JiaLihui PanFan Guo Clinical trial 15 December 2023 Pages: 223 - 235
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY Judith BalmañaPeter A. FaschingThe LUCY investigators Clinical trial Open access 19 December 2023 Pages: 237 - 248
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials Hope S. RugoCatherine H. Van PoznakRobert E. Coleman Clinical trial Open access 20 December 2023 Pages: 249 - 259
Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis Ayane YamaguchiKosuke KawaguchiMasakazu Toi Clinical trial Open access 21 December 2023 Pages: 261 - 275
Prognostic effect of nodal status before and after neoadjuvant chemotherapy in breast cancer: a Dutch population-based study Sabine R. de WildLinetta B. KoppertJanine M. Simons Clinical trial 22 December 2023 Pages: 277 - 288
Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer Faina NakhlisSamuel M. NimanRachel M. Layman Clinical trial 28 December 2023 Pages: 289 - 297
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial Yajing ZhuIoannis ZerdesTheodoros Foukakis Clinical trial Open access 04 January 2024 Pages: 299 - 308
Reproductive risk factors for breast cancer and association with novel breast density measurements among Hispanic, Black, and White women Mollie E. BarnardNatalie C. DuPréRulla M. Tamimi Epidemiology 14 December 2023 Pages: 309 - 325
Psychosocial stressors and breast cancer gene expression in the Black Women’s Health Study Mollie E. BarnardXutao WangJulie R. Palmer Epidemiology 21 December 2023 Pages: 327 - 340
Survival, treatment patterns, and costs of HER2+ metastatic breast cancer patients in Ontario between 2005 to 2020 S. J. SeungH. SaherawalaC. Brezden-Masley Epidemiology 21 December 2023 Pages: 341 - 357
Is there an association between endometriosis and subsequent breast cancer? A retrospective cohort study from Germany Niklas GremkeSebastian GriewingMatthias Kalder Epidemiology Open access 23 December 2023 Pages: 359 - 365
Second primary cancers among females with a first primary breast cancer: a population-based study in Northern Portugal Elisabete GonçalvesFilipa FontesSamantha Morais Epidemiology 27 December 2023 Pages: 367 - 376
Social inequalities in the use of physiotherapy in women diagnosed with breast cancer in Barcelona: DAMA cohort Rocio Cogollos-de-la-PeñaAnaís Álvarez-VargasRosa Puigpinós‑Riera Epidemiology Open access 28 December 2023 Pages: 377 - 387
Targeted axillary dissection: worldwide variations in clinical practice Michalis KontosProdromos KanavidisTAD Study Group Epidemiology 04 January 2024 Pages: 389 - 396
Impact of pre-operative MRI on surgical management of screening digital breast tomosynthesis-detected invasive lobular carcinoma M. BahlB. Deng Original Laboratory Investigation 16 December 2023 Pages: 397 - 405
Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers Melody A. CobleighKayla Viets LayngAbde M. Abukhdeir Original Laboratory Investigation 28 December 2023 Pages: 407 - 414
Subspecialized breast pathologists have suboptimal interobserver agreement in Ki-67 evaluation using 20% as the cutoff Di AiGulisa TurashviliXiaoxian Li Original Laboratory Investigation 29 December 2023 Pages: 415 - 422
Correction to: Clinical characteristics and prognosis of postpartum breast cancer Pill Sun PaikJung Eun ChoiKorean Breast Cancer Society Correction 14 December 2023 Pages: 423 - 423
Correction: FN1-mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer Chen ChenLeiguang YeZhigao Li Correction 28 December 2023 Pages: 425 - 427